khellin and tacrolimus

khellin has been researched along with tacrolimus in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (16.67)29.6817
2010's4 (66.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Alomar, A; Juarez, C; Martínez-Martínez, L; Piquero-Casals, J; Puig, L; Rozas-Muñoz, E1
Berman, B; Poochareon, VN1
Blondel, WC; Chassagne, JF; Gisquet, H; Guillemin, F; Latarche, C; Leroux, A; Liu, H; Merlin, JL; Peiffert, D1
Fang, AH; Lan, CC; Wu, CS; Wu, PH1
Januszyk, M; Kuang, AA; Wong, VW; You, F1

Reviews

1 review(s) available for khellin and tacrolimus

ArticleYear
New therapies for the management of keloids.
    The Journal of craniofacial surgery, 2003, Volume: 14, Issue:5

    Topics: Adrenal Cortex Hormones; Aminoquinolines; Chemotherapy, Adjuvant; Humans; Imiquimod; Immunosuppressive Agents; Interferon alpha-2; Interferon Inducers; Interferon-alpha; Keloid; Laser Therapy; Recombinant Proteins; Tacrolimus

2003

Other Studies

5 other study(ies) available for khellin and tacrolimus

ArticleYear
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
LRP1/CD91 is highly expressed in monocytes from patients with vitiligo - even after repigmentation.
    Experimental dermatology, 2021, Volume: 30, Issue:3

    Topics: Administration, Cutaneous; Adult; Aged; Biomarkers; Case-Control Studies; Chemokine CXCL10; Female; Humans; Immunosuppressive Agents; Khellin; Low Density Lipoprotein Receptor-Related Protein-1; Male; Middle Aged; Monocytes; Severity of Illness Index; Skin Cream; Skin Pigmentation; Tacrolimus; Ultraviolet Therapy; Vasodilator Agents; Vitiligo

2021
Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis.
    Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging (ISSI), 2011, Volume: 17, Issue:2

    Topics: Animals; Cicatrix, Hypertrophic; Dermoscopy; Disease Models, Animal; Ear, External; Female; Hypertrophy; Immunosuppressive Agents; Injections, Intradermal; Keloid; Rabbits; Spectrum Analysis; Tacrolimus; Wounds and Injuries

2011
FK506 inhibits the enhancing effects of transforming growth factor (TGF)-β1 on collagen expression and TGF-β/Smad signalling in keloid fibroblasts: implication for new therapeutic approach.
    The British journal of dermatology, 2012, Volume: 167, Issue:3

    Topics: Adult; Cell Movement; Cell Proliferation; Cells, Cultured; Collagen; Down-Regulation; Female; Fibroblasts; Humans; Immunosuppressive Agents; Keloid; Receptors, Transforming Growth Factor beta; Signal Transduction; Smad Proteins; Tacrolimus; Transforming Growth Factor beta

2012
Tacrolimus fails to regulate collagen expression in dermal fibroblasts.
    The Journal of surgical research, 2013, Volume: 184, Issue:1

    Topics: Cells, Cultured; Cicatrix, Hypertrophic; Collagen; Fibroblasts; Gene Expression; Genome-Wide Association Study; Humans; Immunosuppressive Agents; Keloid; Oligonucleotide Array Sequence Analysis; Principal Component Analysis; Skin; Tacrolimus; Wound Healing

2013
chemdatabank.com